首頁 › COVID-19 後遺症（長新冠） › 北卡羅來納州 › Durham
Durham, NC 的 COVID-19 後遺症（長新冠） 臨床試驗
8 項針對 COVID-19 後遺症（長新冠） 的研究正在 Durham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
招募中3 期
- Research Site, Durham
Long-Term Study of COVID-19 Infection and Long COVID
招募中觀察性研究
- University of North Carolina, Chapel Hill · 距離 10 英里
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
招募中3 期
- Duke Vaccine and Trials Unit, Durham
- Duke Vaccine and Trials Unit, Durham
- Duke University - Main Hospital and Clinics, Durham
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
招募中觀察性研究歡迎健康志工
- Duke University Health System, Durham
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
招募中4 期歡迎健康志工
- Duke Vaccine and Trials Unit, Durham
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
招募中3 期
- Duke University, Durham
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
招募中
- Duke University Health System, Durham
Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity
招募中觀察性研究歡迎健康志工
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 距離 7 英里
其他城市的 COVID-19 後遺症（長新冠） 試驗
- New York City, NY15 項研究
- Houston, TX13 項研究
- Boston, MA13 項研究
- Baltimore, MD12 項研究
- Chicago, IL11 項研究
- Washington, DC10 項研究
- San Francisco, CA8 項研究
- Atlanta, GA8 項研究
- San Diego, CA7 項研究
- Los Angeles, CA6 項研究
- Pittsburgh, PA6 項研究
- Hialeah, FL6 項研究
Durham 的其他研究
- 乳癌64 項研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌39 項研究
- 多發性骨髓瘤37 項研究
- 急性髓系白血病33 項研究
- 轉移性癌症33 項研究
- 前列腺癌32 項研究
- 肺癌32 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 慢性淋巴性白血病27 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。